Well Told Grants

Grants / Department of Health and Human Services / National Institutes of Health

RFA-RM-21-027: The Human BioMolecular Atlas Program (HuBMAP) Demonstration Project (U01 Clinical Trial Not Allowed)

Closed Closed November 19, 2021 Opportunity RFA-RM-21-027

This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2021.

National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on November 19, 2021.

From the official notice on Grants.gov, last changed September 10, 2021. Checked November 7, 2026.

About this NIH notice

Projects funded under RFA-RM-21-027 were run by National Heart Lung and Blood Institute (NHLBI, 2 projects), National Human Genome Research Institute (NHGRI, 1 project) and Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD, 1 project). Contact the program officer at the institute that fits your project before you apply; the notice lists them.

Application due dates, page limits and budget limits are set in the notice. Read RFA-RM-21-027 in the NIH Guide.

Key dates

PostedSeptember 10, 2021
DeadlineNovember 19, 2021
Archived by Grants.govDecember 25, 2021

Who can apply

This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.

All 15 applicant types the notice lists

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses.

Is this a realistic fit?

What the grant funds

The goal of this funding opportunity announcement is to solicit applications that will creatively use datasets and resources from the Human BioMolecular Atlas Program (HuBMAP: https://commonfund.nih.gov/hubmap) to demonstrate their use to address significant biomedical and biological questions. Projects are expected to work closely with the other funded projects as part of the HuBMAP Consortium to provide specific and actionable feedback, validations, tools, software and other resources back to the consortium.

Category: Health.

Funded under RFA-RM-21-027 so far

NIH funded 4 projects under RFA-RM-21-027 in fiscal 2022 to 2025, at 4 institutions. The median yearly award was $478,659.

From NIH RePORTER, which lists each project once per fiscal year it was funded. Amounts are the yearly award.

Who has won Trans-NIH Research Support grants before

From fiscal 2021 to 2025, Trans-NIH Research Support (93.310) awarded $5.9 billion across 4,433 grant awards, an average of $1.3 million per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
Duke UniversityNorth Carolina66$219 million
The Leland Stanford Junior UniversityCalifornia104$176 million
University of Pittsburgh - of the Commonwealth System of Higher EducationPennsylvania82$154 million
The Johns Hopkins UniversityMaryland95$152 million
Yale UnivConnecticut85$149 million

Top states: California ($992 million), Massachusetts ($571 million), New York ($548 million), Pennsylvania ($445 million), North Carolina ($387 million).

Applying now

This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.

Questions people ask

Is RFA-RM-21-027 still open?

No. It closed on November 19, 2021.

Who can apply for The Human BioMolecular Atlas Program (HuBMAP) Demonstration Project (U01 Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

What is the deadline for The Human BioMolecular Atlas Program (HuBMAP) Demonstration Project (U01 Clinical Trial Not Allowed)?

Closed November 19, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.

Who has been funded under RFA-RM-21-027?

NIH RePORTER lists 4 projects funded under RFA-RM-21-027 in fiscal 2022 to 2025, at 4 institutions. The most were at University of Illinois at Chicago, Lurie Children's Hospital of Chicago, Children's Hosp of Philadelphia.

Who has won Trans-NIH Research Support grants before?

The largest recipients over five fiscal years were Duke University, The Leland Stanford Junior University, University of Pittsburgh - of the Commonwealth System of Higher Education. The program made 4,433 awards worth $5.9 billion in that time.

Similar open grants